NCT05680454 2023-01-17
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
Beijing Health Guard Biotechnology, Inc
Phase 1 Completed
Beijing Health Guard Biotechnology, Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins